Negative wound pressure therapy removes fluid and infection from a wound to help it heal. It
is a popular treatment method for acute and chronic wounds caused primarily by chronic
diseases. Chronic diseases are expected to rise as the CIHR (Canadian Institute of Health
Research) reports that 8.8% of the Canadian population has diabetes and 6.1% of Canadian
adults are at high risk of developing diabetes, boosting industry growth.
The negative pressure wound therapy market was worth $2.37 billion in 2021 and is
expected to be worth $3.92 billion by 2030, representing a 5.7% CAGR from 2021 to 2030.
North America had the largest market share, amounting to USD 702 million.
The rise in chronic wounds worldwide is a significant factor driving the growth of the
negative pressure wound therapy market. According to NCBI research, approximately 2% of
the total population in the United States suffers from chronic wounds. Chronic wounds are
most commonly associated with chronic diseases.
Along with increased chronic wounds in the population, new and improved harmful pressure
wound therapy devices and methods have also contributed to market growth. Negative
pressure wound therapy devices such as PICO VAC dressing, negative pressure pump,
wound pump, portable wound VAC, NPWT wound VAC, Smith Nephew PICO 7, Medela
Wound VAC, negative pressure dressing, wound VAC dressing, NPWT dressing, and the
PICO wound VAC is used to treat chronic wounds as a result of procedures such as wound
VAC therapy, VAC dressing pressure, and negative pressure therapy.
the cost of NPWT is higher than the cost of traditional therapy. For instance, according to a
study by BioMedCentral, the price per patient treated with NPWT is $142 higher than the
price per patient treated with traditional techniques.
Because there are fewer healthcare experts trained in NPWT techniques and devices, the
treatment of patients who require such procedures is hampered.
The advancement of technologies in NPWT allows patients’ wounds to heal faster. While the
technology is costly to set up, the therapy itself is inexpensive. This represents a truthful
opportunity for growth in the negative pressure wound therapy market.
By products, the market is segmented into NPWT accessories, Conventional NPWT devices,
and single-use NPWT devices.
Due to their high price and increasing adoption, conventional devices accounted for the
largest revenue share of 88.0% in 2021. Because they use heavy canisters, such systems
require hospitalization and are inappropriate for home care settings. Because of their low
purchasing power, these devices can be rented and purchased, which is likely to boost the
usage rate of NPWT in developing countries.
Wound Type insights
On the basis of wound type, the market is segmented into acute and chronic wounds.
With a CAGR of around 6%, the ‘Chronic Wound segment accounted for the largest market
size in 2019. This is because chronic diseases among people are expected to rise, possibly
resulting in long-term wounds. According to the NCBI, chronic wounds affect 6.5 million
people in the United States.
The NPWT market is segmented based on end-users into homecare, hospitals, and clinics.
Because conventional devices are widely used in hospital settings, the hospital segment ruled
the market and accounted for a revenue share of 52.5% in 2021. During the forecast period,
the home care setting is expected to be the fastest-growing segment with the highest CAGR.
With the introduction of single-use NPWT systems, NPWT therapy for homecare settings is
gaining traction. These products eliminate hospital stays, making overall therapy more cost-
effective when used at home.
In terms of region, North America dominated the market in 2021, accounting for up to 38%
of the share. The introduction of low-cost NPWT technology, a growing geriatric population,
and an increase in chronic wound cases all contributed to significant growth in this region.
According to the Agency for Healthcare Research and Quality, more than 2.5 million people
in the United States suffer from pressure ulcers.
However, the Asia-Pacific region had the fastest CAGR during the forecast period. The rapid
increase in chronic wounds due to chronic diseases in this region and technological advances
in NPWT devices are the primary factors driving the market growth. Diabetes affects
approximately 1.07 billion people in China between the ages of 20 and 79, according to the
International Diabetes Federation.
The businesses focus on mergers and acquisitions, new product development, and
Major players in the market are:
Smith & Nephew
Paul Hartmann AG
Talley Group Limited
Devon Medical Products